A new chemotherapy-free treatment for newly diagnosed patients with follicular lymphoma is being studied by SCCA. The RELEVANCE trial is evaluating lenalidomide (Revlimid) with rituximab to improve the response rates and progression-free survival. Lenalidimide helps the bone marrow produce normal blood cells and kills cancer cells; it is currently used to treat myelodysplastic syndrome and [...]
-
Recent Posts
- SCCA Cancer News Watch
- Global Cancer Care Events This Week at SCCA
- More BRCA1 and BRCA2 Patent News
- Our Bodies, Our Genes
- Get Jesse Story Prompts Review of Health Care Plan’s Mammogram Policy
- From One to Many: Finding a Cure for HIV
- SCCA Clinical Trial Openings
- Bob’s Kickin’ Cancer Soap
- Pancreas Cancer: A Glimmer of Hope
- Phyt Back! Strawberry-Spinach Salad
Sites and Blogs We Follow
Video Interviews with SCCA Doctors
Categories
SCCA Blog
